Paul Knight

Stock Analyst at KeyBanc

(2.94)

# 2,642

Out of 4,444 analysts

260

Total ratings

42.4%

Success rate

2.3%

Average return

Main Sectors:

Healthcare Industrials Technology

Top Industries:

Diagnostics & Research Medical Instruments & Supplies Medical Devices Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Paul Knight

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CSTL Castle Biosciences	Maintained: Buy	$50 → $35	$22.12	+58.23%	9	May 29, 2026
	RPID Rapid Micro Biosystems	Maintained: Buy	$8 → $5	$1.69	+196.74%	3	May 29, 2026
	CYRX Cryoport	Maintained: Buy	$15 → $17	$15.52	+9.54%	10	May 20, 2026
	TECH Bio-Techne	Maintained: Hold	n/a	$58.88	-	19	May 7, 2026
	XGN Exagen	Maintained: Buy	$15 → $10	$4.52	+121.24%	11	Mar 11, 2026
	STVN Stevanato Group	Rated: Buy	$37 → $32	$17.24	+85.61%	7	Mar 5, 2026
	TKNO Alpha Teknova	Maintained: Hold	n/a	$5.20	-	4	Feb 27, 2026
	LAB Standard BioTools	Maintained: Hold	n/a	$0.753	-	9	Feb 25, 2026
	RGEN Repligen	Maintained: Buy	$220	$138.40	+58.96%	13	Feb 25, 2026
	LFCR Lifecore Biomedical	Maintained: Hold	n/a	$5.81	-	3	Dec 29, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Buy	$310	$188.87	+64.13%	9	Dec 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	$750	$492.20	+52.38%	9	Dec 8, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$325 → $350	$340.41	+2.82%	15	Oct 24, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	€415.00 → €320.00	$219.40	+45.85%	2	Oct 7, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$33	$25.57	+29.06%	10	Oct 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$125	$105.63	+18.34%	12	Sep 16, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$220	$124.28	+77.02%	2	Sep 10, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	CHF 525.00	$353.00	+48.73%	1	Sep 4, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$131.63	-	12	Aug 28, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$460	$369.18	+24.60%	9	Aug 18, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	$40 → $30	$9.69	n/a	3	Jun 3, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$7 → $30	$6.10	n/a	9	Apr 9, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$26.00	n/a	2	Mar 31, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Hold	n/a	$94.45	n/a	3	Feb 5, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	CHF 610.00 → CHF 635.00	$528.40	n/a	6	Jan 30, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$5.76	n/a	9	May 9, 2024
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	n/a	$23.86	n/a	9	Nov 14, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$300	$202.10	n/a	1	May 5, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	$250	$185.62	n/a	1	Apr 28, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$5.38	n/a	6	Mar 14, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$1.70	n/a	1	Apr 15, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	$20 → $30	$12.90	n/a	3	Feb 27, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$6 → $2	$0.0004	n/a	8	Nov 26, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$6.14	n/a	2	Jul 24, 2019
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$56.76	n/a	7	Nov 29, 2018
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Hold	n/a	$175.09	n/a	6	Oct 23, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$58.44	n/a	4	Mar 27, 2017
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	n/a	$1.26	n/a	2	Mar 11, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Buy	n/a	$27.13	n/a	1	Feb 10, 2016
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	$75 → $85	$222.16	n/a	2	Jul 24, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	n/a	$2.61	n/a	1	May 5, 2014
	XXXX XXXXXXXXXXXXXXXX Upgrade	Rated: Hold	$61 → $46	$9.18	n/a	2	Dec 19, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$255	$1,203.18	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$24	$38.73	n/a	1	Aug 15, 2013
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiated Coverage: Hold	$18	$0.47	n/a	1	Aug 15, 2013

Castle Biosciences

May 29, 2026

Maintained: Buy

Price Target: $50 → $35

Current: $22.12

Upside: +58.23%

Rapid Micro Biosystems

May 29, 2026

Maintained: Buy

Price Target: $8 → $5

Current: $1.69

Upside: +196.74%

Cryoport

May 20, 2026

Maintained: Buy

Price Target: $15 → $17

Current: $15.52

Upside: +9.54%

Bio-Techne

May 7, 2026

Maintained: Hold

Price Target: n/a

Current: $58.88

Upside: -

Exagen

Mar 11, 2026

Maintained: Buy

Price Target: $15 → $10

Current: $4.52

Upside: +121.24%

Stevanato Group

Mar 5, 2026

Rated: Buy

Price Target: $37 → $32

Current: $17.24

Upside: +85.61%

Alpha Teknova

Feb 27, 2026

Maintained: Hold

Price Target: n/a

Current: $5.20

Upside: -

Standard BioTools

Feb 25, 2026

Maintained: Hold

Price Target: n/a

Current: $0.753

Upside: -

Repligen

Feb 25, 2026

Maintained: Buy

Price Target: $220

Current: $138.40

Upside: +58.96%

Lifecore Biomedical

Dec 29, 2025

Maintained: Hold

Price Target: n/a

Current: $5.81

Upside: -

Dec 18, 2025

Rated: Buy

Price Target: $310

Current: $188.87

Upside: +64.13%

Dec 8, 2025

Upgraded: Buy

Price Target: $750

Current: $492.20

Upside: +52.38%

Oct 24, 2025

Maintained: Buy

Price Target: $325 → $350

Current: $340.41

Upside: +2.82%

Oct 7, 2025

Maintained: Buy

Price Target: €415.00 → €320.00

Current: $219.40

Upside: +45.85%

Oct 3, 2025

Maintained: Buy

Price Target: $33

Current: $25.57

Upside: +29.06%

Sep 16, 2025

Maintained: Buy

Price Target: $125

Current: $105.63

Upside: +18.34%

Sep 10, 2025

Maintained: Buy

Price Target: $220

Current: $124.28

Upside: +77.02%

Sep 4, 2025

Initiated Coverage: Buy

Price Target: CHF 525.00

Current: $353.00

Upside: +48.73%

Aug 28, 2025

Reiterated: Hold

Price Target: n/a

Current: $131.63

Upside: -

Aug 18, 2025

Maintained: Buy

Price Target: $460

Current: $369.18

Upside: +24.60%

Jun 3, 2025

Reiterated: Buy

Price Target: $40 → $30

Current: $9.69

Upside: n/a

Apr 9, 2025

Downgraded: Hold

Price Target: $7 → $30

Current: $6.10

Upside: n/a

Mar 31, 2025

Downgraded: Hold

Price Target: n/a

Current: $26.00

Upside: n/a

Feb 5, 2025

Reiterated: Hold

Price Target: n/a

Current: $94.45

Upside: n/a

Jan 30, 2025

Maintained: Buy

Price Target: CHF 610.00 → CHF 635.00

Current: $528.40

Upside: n/a

May 9, 2024

Rated: Hold

Price Target: n/a

Current: $5.76

Upside: n/a

Nov 14, 2023

Rated: Hold

Price Target: n/a

Current: $23.86

Upside: n/a

May 5, 2022

Maintained: Buy

Price Target: $300

Current: $202.10

Upside: n/a

Apr 28, 2022

Maintained: Buy

Price Target: $250

Current: $185.62

Upside: n/a

Mar 14, 2022

Downgraded: Hold

Price Target: n/a

Current: $5.38

Upside: n/a

Apr 15, 2020

Initiated Coverage: Buy

Price Target: n/a

Current: $1.70

Upside: n/a

Feb 27, 2020

Maintained: Hold

Price Target: $20 → $30

Current: $12.90

Upside: n/a

Nov 26, 2019

Downgraded: Hold

Price Target: $6 → $2

Current: $0.0004

Upside: n/a

Jul 24, 2019

Downgraded: Hold

Price Target: n/a

Current: $6.14

Upside: n/a

Nov 29, 2018

Downgraded: Hold

Price Target: n/a

Current: $56.76

Upside: n/a

Oct 23, 2017

Upgraded: Hold

Price Target: n/a

Current: $175.09

Upside: n/a

Mar 27, 2017

Downgraded: Hold

Price Target: n/a

Current: $58.44

Upside: n/a

Mar 11, 2016

Downgraded: Hold

Price Target: n/a

Current: $1.26

Upside: n/a

Feb 10, 2016

Initiated Coverage: Buy

Price Target: n/a

Current: $27.13

Upside: n/a

Jul 24, 2014

Downgraded: Hold

Price Target: $75 → $85

Current: $222.16

Upside: n/a

May 5, 2014

Upgraded: Buy

Price Target: n/a

Current: $2.61

Upside: n/a

Dec 19, 2013

Rated: Hold

Price Target: $61 → $46

Current: $9.18

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $255

Current: $1,203.18

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $24

Current: $38.73

Upside: n/a

Aug 15, 2013

Initiated Coverage: Hold

Price Target: $18

Current: $0.47

Upside: n/a